Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study

por Gbolahan, Olumide B., Tong, Yan, Sehdev, Amikar, O’Neil, Bert, Shahda, Safi
Publicado 2019

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma

por El Hajj, Ihab I., Lawrence, Karen A., Tirkes, Temel, Shahda, Safi, Sherman, Stuart
Publicado 2018

Erythema multiforme as a presentation of COVID-19: Case Illustrated format

por Ahmed, Shahda Mohamed Alhassan, Olajide, Tinuola, Albsheer, Khalid Mohamed Ibraheem Alhaj, Danjuma, Sushil Niraula
Publicado 2022

Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

por Shahda, Safi, Loehrer, Patrick J., Clark, Romnee S., Spittler, A. John, Althouse, Sandra K., Chiorean, E. Gabriella
Publicado 2016

Biosynthesis of Sinapigladioside, an Antifungal Isothiocyanate from Burkholderia Symbionts

por Dose, Benjamin, Niehs, Sarah P., Scherlach, Kirstin, Shahda, Sophie, Flórez, Laura V., Kaltenpoth, Martin, Hertweck, Christian
Publicado 2021

COVID-19-Pandemiekrisenstäbe: Organisation, Befugnisse und Herausforderungen – Strukturelle Gegebenheiten verstehen und nutzen

por Klinger, Isabell, Heckel, Maria, Shahda, Sophie, Krisen, Ursula, Stellmacher, Silke, Kurkowski, Sandra, Junghanß, Christian, Ostgathe, Christoph
Publicado 2022

COVID-19: Challenges and solutions for the provision of care to seriously ill and dying people and their relatives during SARS-CoV-2 pandemic – perspectives of pandemic response te...

por Klinger, Isabell, Heckel, Maria, Shahda, Sophie, Kriesen, Ursula, Schneider, Carolin, Kurkowski, Sandra, Junghanss, Christian, Ostgathe, Christoph
Publicado 2022

Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis

por Gu, Dongsheng, Lin, Hai, Zhang, Xiaoli, Fan, Qipeng, Chen, Shaoxiong, Shahda, Safi, Liu, Yunlong, Sun, Jie, Xie, Jingwu
Publicado 2018

Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report

por Alhassan, Shahda Mohamed, Iqbal, Phool, Fikrey, Lubna, Mohamed Ibrahim, Mohanad Ibrahim, Qamar, Muhammad Sohaib, Chaponda, Masautso, Munir, Waqar
Publicado 2020

APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival

por Cardoso, Angelo A., Jiang, Yanlin, Luo, Meihua, Reed, April M., Shahda, Safi, He, Ying, Maitra, Anirban, Kelley, Mark R., Fishel, Melissa L.
Publicado 2012

PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC L...

por Jurczak, W., Dartigeas, C., Coscia, M., Ganly, P., Al-Jazayrly, G., Wang, C., Bao, K., Leow, C. C., Shahda, S., Zinzani, P. L.
Publicado 2022

Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin

por Zhong, Xiaoling, Narasimhan, Ashok, Silverman, Libbie M., Young, Andrew R., Shahda, Safi, Liu, Sheng, Wan, Jun, Liu, Yunlong, Koniaris, Leonidas G., Zimmers, Teresa A.
Publicado 2022

Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer

por Kays, Joshua K., Shahda, Safi, Stanley, Melissa, Bell, Teresa M., O'Neill, Bert H., Kohli, Marc D., Couch, Marion E., Koniaris, Leonidas G., Zimmers, Teresa A.
Publicado 2018

Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform

por Narasimhan, Ashok, Shahda, Safi, Kays, Joshua K., Perkins, Susan M., Cheng, Lijun, Schloss, Katheryn N. H., Schloss, Daniel E. I., Koniaris, Leonidas G., Zimmers, Teresa A.
Publicado 2020

PB1864: BRUIN CLL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR’S CHOICE OF IDELALISIB+RITUXIMAB OR BENDAMUSTINE+RITUXIMAB IN BTKI PRETREATED CLL/SLL...

por Sharman, J. P., Jurczak, W., Coombs, C. C., Hill, M., Wang, D., Ku, N. C., Guntur, A., Shahda, S., Leow, C. C., Ghia, P., Mato, A. R.
Publicado 2022

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors

por Beatty, Gregory L., Shahda, Safi, Beck, Thaddeus, Uppal, Nikhil, Cohen, Steven J., Donehower, Ross, Gabayan, Afshin Eli, Assad, Albert, Switzky, Julie, Zhen, Huiling, Von Hoff, Daniel D.
Publicado 2018

PB1863: BRUIN CLL-322: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB+VENETOCLAX AND RITUXIMAB VS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CLL/SLL (TR...

por Mato, A. R., Wierda, W. G., Pagel, J. M., Davids, M. S., Zinzani, P. L., Lu, Y., Liu, H., Shahda, S., Leow, C. C., Tam, C. S., Woyach, J. A., Eyre, T. A.
Publicado 2022

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic...

por Davis, S. Lindsey, Cardin, Dana B., Shahda, Safi, Lenz, Heinz-Josef, Dotan, Efrat, O’Neil, Bert H., Kapoun, Ann M., Stagg, Robert J., Berlin, Jordan, Messersmith, Wells A., Cohen, Steven J.
Publicado 2019

Prevalence, Outcome, and Optimal Management of Free-Floating Right Heart Thrombi in the Context of Pulmonary Embolism, a Systematic Review and Meta-Analysis

por Ibrahim, Wanis H., Ata, Fateen, Choudry, Hassan, Javed, Huzaifa, Shunnar, Khaled M, Shams, Abdullah, Arshad, Abdullah, Bosom, Adel, Elkahlout, Mohammed H.A., Sawaf, Bisher, Ahmed, Shahda M.A., Olajide, Tinuola
Publicado 2022

Efficacy of ablation therapy on clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis

por Zahoor, Mohammad Munim, Ullah, Saad Ehsan, Kidiavai, Harriet Mmaitsi, Eltieb, Shahda A.H, Devi, Anjuli, Asif, Muhammad Anis, Vaswani, Akshay, Hyder, Ammar, Hoti, Muhammad Roshan, Jawad, Sayed, Arshid, Sana, Shankar, Abhirami, Salman, Muhammad
Publicado 2023